netFormulary NHS
Herefordshire & Worcestershire
Medicines and Prescribing Committee
 Search
 Formulary Chapter 5: Infections - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01 Antibacterial drugs (0,0)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (2,0)
05.01.01.02 Penicillinase-resistant penicillins (1,1)
05.01.01.03 Broad-spectrum penicillins (2,2)
05.01.01.04 Antipseudomonal penicillins (1,0)
05.01.01.05 Mecillinams (0,0)
05.01.02 Cephalosporins, carbapenems and other beta-lactams (0,0)
05.01.02.01 Cephalosporins (7,0)
05.01.02.02 Carbapenems (3,0)
05.01.02.03 Other beta-lactams antibiotics (1,1)
05.01.03 Tetracyclines (4,0)
Tigecycline (1,0)
05.01.04 Aminoglycosides (4,1)
05.01.05 Macrolides (4,1)
05.01.06 Clindamycin (1,0)
05.01.07 Some other antibacterials (3,0)
Chloramphenicol (0,0)
Fosfomycin (0,0)
Fusidic acid (1,0)
Vancomycin and teicoplanin (2,0)
Daptomycin (1,0)
Linezolid (1,0)
Quinupristin and dalfopristin (0,1)
Polymyxins (1,0)
05.01.08 Sulphonamides and trimethoprim (2,1)
05.01.09 Antituberculosis drugs (8,5)
05.01.10 Antileprotic drugs (1,1)
05.01.11 Metronidazole and tinidazole (1,0)
05.01.12 Quinolones (4,0)
05.01.13 Urinary-tract infections (4,2)
05.02 Antifungal drugs (0,0)
05.02.01 Triazole antifungals (4,0)
05.02.02 Imidazole antifungals (3,0)
05.02.03 Polyene antifungals (3,0)
05.02.04 Echinocandin antifungals (3,0)
05.02.05 Other antifungals (2,1)
05.03 Antiviral drugs (1,0)
05.03.01 HIV infection (0,0)
Nucleoside reverse transcriptase inhibitors (16,0)
Protease inhibitors (11,1)
Non-nucleoside reverse transcriptase inhibitors (3,0)
Other antiretrovirals (5,0)
Pharmacokinetic enhancers of antiretrovirals (1,0)
Combination Products (0,0)
05.03.02 Herpesvirus infections (0,0)
05.03.02.01 Herpes simplex and varicella-zoster infection (2,2)
05.03.02.02 Cytomegalovirus infrection (4,0)
05.03.03 Viral hepatitis (0,0)
05.03.03.01 Chronic hepatitis B (2,0)
05.03.03.02 Chronic hepatitis C (6,0)
05.03.04 Influenza (3,1)
05.03.05 Respiratory syncytial virus (5,0)
05.04 Antiprotozoal drugs (0,0)
05.04.01 Antimalarials (0,0)
Falciparum malaria (treatment) (0,0)
Benign malarias (treatment) (0,0)
Specific recommendations (0,0)
Artemether with lumefabtrine (1,0)
Chloroquine (1,0)
Mefloquine (0,1)
Primaquine (0,1)
Proguanil (0,2)
Pyrimethamine (0,3)
Quinine (1,0)
Tetracyclines (0,0)
05.04.02 Amoebicides (0,2)
05.04.03 Trichomonacides (0,0)
05.04.04 Antigiardial drugs (0,0)
05.04.05 Leishmaniacides (2,0)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (0,0)
05.04.08 Drugs for pneumocystis pneumonia (1,2)
Treatment (0,0)
Prophylaxis (0,0)
05.05 Anthelmintics (0,0)
05.05.01 Drugs for threadworms (3,0)
05.05.02 Ascaricides (0,0)
05.05.03 Drugs for tapeworm infections (0,0)
Taenicides (0,0)
Hydatid disease (0,0)
05.05.04 Drugs for hookworms (0,0)
05.05.05 Schistosomicides (0,0)
05.05.06 Filaricides (0,0)
05.05.07 Drugs for cutaneous larva migrans (0,0)
05.05.08 Drugs for strongyloidiasis (0,0)
netFormulary